Pregvit

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pregvit

Property Description
Active Ingredients Complex of multiple vitamins and minerals (e.g., Folic Acid, Iron, Calcium, B-vitamins)
Form Oral tablet
Pharmacological Class Multivitamin and Mineral Preparation
Common Use Nutritional support and supplementation
Origin Combination of synthetic vitamins and mineral salts

What Type of Preparation Is Pregvit?

Pregvit is classified as a Multivitamin and Mineral Preparation intended for nutritional support, supplied as an oral tablet. This formulation is a combination product that delivers a complex array of essential substances, distinguishing it from supplements focused on a single deficiency. The product’s pharmaceutical classification is determined by its comprehensive mixture of vitamins and minerals, which includes both the synthetic forms of vitamins and various mineral salts. This preparation falls under the Anatomical Therapeutic Chemical (ATC) code B03AE04 (Iron, Multivitamins, and Minerals) and is positioned as a Vitamin-Mineral Supplement Tablet. Such complex micronutrient profiles are utilized for maintaining systemic nutritional integrity.

The Essential Micronutrient Composition of Pregvit

Pregvit’s composition comprises multiple essential micronutrients, which function as necessary co-factors for various metabolic processes in the body. Key components include the full spectrum of B-vitamins (Thiamine, Riboflavin, Niacin, Pyridoxine, and Cobalamin), fat-soluble Cholecalciferol (Vitamin D3) and Tocopherol (Vitamin E), and water-soluble Ascorbic Acid (Vitamin C), alongside Beta Carotene. Critical mineral content includes Calcium, Iron (typically supplied as Ferrous Fumarate), Magnesium, Iodine, and Copper. These micronutrients are involved in supporting metabolic functions and preventing deficiency states.

General Purpose: Nutritional Support and Physiological Balance

The overall purpose of this complex formulation is to provide comprehensive nutritional support by helping to fill potential dietary deficiencies in micronutrient intake. A typical use scenario involves supplementing the diet of individuals to ensure the consistent availability of these necessary elements, which directly contributes to supporting general physiological balance across various bodily systems. The preparation functions to promote normal metabolic and cellular processes through consistent micronutrient availability, rather than being directed toward treating a specific disease or condition.

Regulatory References

  1. Health Canada Drug Product Database (DPD)
  2. Product information - Pregvit (DIN: 02451573)

What side effects are possible with Pregvit?

Possible Side Effects and Safety Information

The safety profile of this multivitamin and mineral preparation is defined by formally documented adverse reactions and critical constraints outlined in government regulatory labeling, such as the Health Canada Product Monograph.

Officially Documented Adverse Reactions

The most frequently cited adverse reactions associated with this type of preparation primarily involve the Gastrointestinal system-organ class. These reactions are typically categorized as common or expected effects and include:

  • Constipation
  • Diarrhea
  • Nausea
  • Gastric Irritation

Serious Safety Considerations and Constraints

The official labeling includes several critical warnings and limitations related to the product’s composition and specific patient circumstances, which define the high-risk safety profile:

  • Risk of Pediatric Iron Poisoning: The product contains a concentration of iron that poses a risk of severe and potentially fatal iron poisoning if accidentally ingested by a child. This is a primary, explicit safety warning regarding the composition.
  • Vitamin B12 Deficiency Constraint: The folic acid component may mask the symptoms of an underlying, uncorrected Vitamin B12 deficiency, potentially leading to serious and untreated problems of the nervous system.
  • Drug-Seizure Interaction: In individuals with controlled seizure disorders taking certain anticonvulsant medications, the folic acid content may increase the likelihood of experiencing seizures.

Regulatory documents do not use standard frequency bands (e.g., Common, Uncommon) for the listed gastrointestinal effects but refer to them as the most common adverse reactions. These restrictions and warnings are mandatory components of the product's official safety framework.

Overdose and Emergency Response

Overdose and when to seek help — Official Regulatory Information

The official regulatory profile for this multivitamin and mineral preparation is defined by the acute toxicity risk associated with its elemental iron content. Immediate medical attention is required in all cases of suspected or confirmed overdose.

Overdose Risk and Symptoms Emergency Actions Mandated by Regulators
Documented Manifestations: Initial symptoms of overdose may include severe nausea, vomiting, abdominal pain, and diarrhea. These manifestations can progress to include signs of shock, pallor, and profound drowsiness or coma.
Seek Immediate Help: In all cases of known or suspected overdose, seek professional medical assistance immediately and call a doctor or Poison Control Center right away.
Severe Outcomes: Overdose is classified as potentially severe and life-threatening due to the risk of cardiovascular collapse, severe metabolic acidosis, and acute hepatic failure.
Required Procedures: Management typically involves symptomatic and supportive treatment, including intravenous fluid resuscitation and continuous hospital monitoring. Specific therapy with chelating agents may be required in severe cases.
Population Warning: Accidental overdose of iron-containing products is the leading cause of fatal poisoning in children under six years of age. Ingestion of elemental iron above 60 mg/kg is associated with severe toxicity risk.
Monitoring: Hospital observation is necessary. The severity of the overdose is best assessed by measuring serum iron levels approximately four hours after ingestion.

Therapeutic Uses of Pregvit

What Pregvit Treats: Main Uses and Benefits

This supplement is commonly used to help with symptoms related to systemic imbalance that stem from vitamin and mineral inadequacy, such as feelings of fatigue or low energy, which may occur due to the body's increased nutrient demands during pregnancy or breastfeeding. It provides supportive therapeutic benefit by supporting the maintenance of the mother's nutritional status, which contributes to improved comfort during periods of heightened symptoms.

The core therapeutic domains include managing symptoms of nutritional insufficiency, supporting healthy fetal development, and maintaining maternal well-being during and after pregnancy. A crucial use is to supply essential nutrients, such as folic acid, that are necessary for the proper development of the baby's nervous system, supporting the development of the baby's brain and spinal cord. Adequate folic acid intake before and during the early weeks of pregnancy may help reduce the risk of certain developmental abnormalities like neural tube defects. This preventive action supports the healthy formation of the developing fetus.


Quick Fact: Relief for Fatigue


“This type of supplementation is considered relevant in contexts involving heightened systemic burden and contributes to general well-being during the physical demands of pregnancy and recovery.”

Regulatory References

  1. Health Canada in their guidance on Folic Acid and Healthy Pregnancy

Eligibility and Restrictions for Use

Pregvit is officially intended for use by individuals who are planning a pregnancy (periconceptional period), pregnant, or breastfeeding/lactating. This regulatory classification limits its standard use to the specific physiological states associated with childbearing and postpartum nutritional support.

Absolute restrictions are defined by official regulatory bodies. The medication must not be used by any individual with a known hypersensitivity or allergy to the vitamins, minerals, or any other component in the formulation. Furthermore, the product is not intended for children. Due to the concentration of iron, accidental ingestion by a child poses a serious risk of fatal iron poisoning, leading to a formal age-based exclusion.

Certain pre-existing health conditions necessitate conditional use and careful professional oversight. Patients with a known Vitamin B12 deficiency must be monitored or co-supplemented, as the folic acid component may conceal the neurological symptoms of the deficiency. Caution is also required for patients with a seizure disorder who are taking anticonvulsant medications, as regulatory information suggests a potential for increased seizure activity.

What should I know about interactions with other medicines?

Documented Interactions with Other Medicines and Products

Official regulatory documents detail specific interactions for Pregvit, primarily concerning the mineral and folic acid components. These interactions typically require time separation or cautionary co-administration.

Interacting Substance/Class Component Involved Official Description/Requirement
Thyroid Hormone Medications (e.g., Levothyroxine) Iron Iron may reduce the hormone's absorption, requiring a four-hour separation between doses.
Antiepileptic Drugs (AEDs) (e.g., Phenytoin, Carbamazepine) Folic Acid The combination may result in an increase in seizures; co-administration must be managed with caution.
Antacids Folic Acid Antacids can reduce the absorption of the folic acid component.
Antibiotic Therapy Folic Acid Can disrupt gastrointestinal flora, potentially interfering with Folic Acid absorption.

Timing-Based Administration Rules

The two distinct tablets, the pink (a.m.) and the blue (p.m.), must be taken at least four hours apart to prevent the mineral components (Iron and Calcium/Folic Acid) from interacting and reducing the absorption of Iron. This time separation is a mandatory requirement to optimize the uptake of key nutrients.

Population-Specific Interaction Notes

Individuals with a confirmed Vitamin B12 deficiency should receive concomitant Vitamin B12 supplementation when taking folic acid to avoid potential nervous system problems. Doses of folic acid over 1, mg per day may require laboratory monitoring of Vitamin B12 levels.

Mechanism of Action

The mechanism of action for the components of Pregvit involves essential enzymatic cofactor activity and systemic ion transport. mathbfFolic mathbfacid (Vitamin B9) is biologically inert and requires reduction by the enzyme dihydrofolate reductase (DHFR) to its active cofactors, primarily tetrahydrofolate (THF). THF is a crucial one-carbon unit donor in the folate cycle, essential for the de novo synthesis of purines and thymidylates, which are rate-limiting precursors for DNA and RNA. Folic acid thus directly modulates cell division and proliferation pathways, particularly in rapidly dividing cells like those in the bone marrow and developing tissues.

Iron is absorbed via ferroportin and incorporated into the heme structure via ferrochelatase within erythroid precursors. Heme is an indispensable component of hemoglobin, which mediates oxygen transport from the pulmonary circulation to peripheral tissues. mathbfVitamin mathbfB12 (Cyanocobalamin) functions as a cofactor for two key enzymes: methionine synthase and L-methylmalonyl-CoA mutase. Methionine synthase is necessary for the regeneration of THF from 5-methyltetrahydrofolate, thereby interconnecting the folate and mathbfB12 pathways. mathbfVitamin mathbfB6 (Pyridoxine) serves as a cofactor in numerous metabolic transformations, including the synthesis of neurotransmitters and the regulation of homocysteine levels. The combined systemic effect is the modulation of nucleic acid synthesis, oxygen transport capacity, and critical cellular metabolic cycles.

Dosage and Administration Information

How to Use Pregvit

The administration guidelines for Pregvit consist of a daily, split-dose regimen of one pink tablet and one dark blue tablet. The tablets are for oral use and must not be crushed, chewed, or split, but swallowed whole with a glass of water.


Official Administration Schedule

The dosing schedule involves taking one pink (a.m.) tablet and one dark blue (p.m.) tablet daily, with a separation period to ensure proper absorption of key nutrients.

Tablet Timing Special Condition
Pink (a.m.) In the morning on an empty stomach (one hour before or two hours after a meal). Do not consume food for one hour after administration.
Dark Blue (p.m.) Close to the evening meal (before or after, i.e., within one hour of the meal). Must be taken at least four hours after the pink tablet.

Missed Dose Instructions

If a dose is missed, the tablet should be taken as soon as possible, and the regular schedule should then be resumed. Guidance indicates not to take two doses at the same time to make up for a missed dose. The four-hour separation between the pink and blue tablets should still be observed.

Recent Clinical Evidence

Research evidence / Overview of studies for Pregvit

Evidence for Preventing Neural Tube Defects (NTDs)

The main way Pregvit was studied for is to evaluate patterns related to the recurrence of Neural Tube Defects (NTDs) in women at high risk. Research has primarily examined its key ingredient, high-dose folic acid, along with vitamin B12, in women who have previously had a pregnancy affected by an NTD. This approach was evaluated in clinical trials, including randomized controlled trials, which research describes as a key method to understand what has been observed in studies.

These studies generally suggest that taking high-dose folic acid before and during the early stages of pregnancy was associated with observed patterns related to recurrence in the observed high-risk populations. The findings describe patterns observed in the studies of women at high risk. However, it is important to understand that the results apply only to the populations studied.


Evidence for Use in Other Pregnancy-Related Contexts

Beyond the primary indication involving NTD recurrence, research has explored whether supplements like Pregvit may be relevant in other pregnancy-related contexts. Studies were observed in broader populations of pregnant individuals to monitor nutrient levels and observations related to physiological states sometimes seen during pregnancy. Although the research has explored the role of its ingredients in a broader context, studies specifically on Pregvit's effect on outcomes reflecting daily functioning or activity level in a general pregnancy population are not fully established.


Long-term Studies and Follow-up

Research was studied for the long-term patterns following the use of high-dose folic acid and B12 during pregnancy. These studies typically monitor children born to mothers who took the supplement over defined time intervals to see how they developed. Follow-up durations were limited in some research, meaning data are still emerging regarding the duration of the observed patterns. Certainty remains low for many of these long-term aspects, and comprehensive research is ongoing to fill these knowledge gaps.


What is Still Uncertain About Pregvit

Limitations remain in the research. One area where findings were mixed relates to the optimal dose of B12 needed in combination with high-dose folic acid in some specific metabolic contexts. Another limitation is that sample sizes were modest in some of the subgroup analyses. There is limited information for long-term outcomes that look at non-NTD related developmental outcomes. Ultimately, the study results reflect the specific conditions under which they were conducted, and research is ongoing to explore remaining questions surrounding this supplement.

Key Studies & References

  1. Beyond Folate: The Emerging Role of Maternal Vitamin B12 in Neural Tube Development (Systematic Review and Meta-analysis)
  2. Folic Acid Supplementation for the Prevention of Neural Tube Defects: An Updated Evidence Report and Systematic Review - USPSTF

Frequently Asked Questions (FAQ)

Common questions about Pregvit (FAQ)


Q: What is the main difference between Pregvit and a standard prenatal vitamin?

A: Official information describes this product as a split-dose preparation, consisting of two different tablets taken hours apart. This regimen is a design feature intended to optimize the absorption of key mineral components, such as Iron and Calcium. The specific components and dosage levels may differ from those found in single-tablet prenatal supplements.


Q: Is it normal to feel slightly nauseous after taking Pregvit?

A: Yes, nausea is officially documented as one of the commonly reported gastrointestinal adverse reactions associated with this type of preparation. The official administration schedule involves taking one of the tablets on an empty stomach in the morning. This timing of administration is mandated in the product information.


Q: Are there any common supplements or vitamins that should not be taken with Pregvit?

A: Regulatory information primarily addresses the need to avoid the interference of certain mineral components. The official product information addresses the mandatory time separation between the two tablets for optimal uptake. The product label advises informing your healthcare provider about all non-prescription or natural health products being taken.


Q: Is it true that the iron in Pregvit is less likely to cause constipation than other prenatal vitamins?

A: Study data summarized in the official regulatory documentation suggests that this preparation was associated with a lower rate and shorter duration of constipation compared to a supplement containing a higher dose of iron. However, it is important to note that constipation is still officially listed as a possible gastrointestinal adverse reaction.


Q: What kind of studies support the use of Pregvit during pregnancy planning?

A: The preparation is officially intended for use during the periconceptional period (when planning a pregnancy). The main body of research evidence primarily examines the role of its key ingredients, like high-dose folic acid, in patterns related to the recurrence of Neural Tube Defects (NTDs) when taken before and during the early stages of pregnancy.


Q: Can taking too much Pregvit cause a vitamin overdose?

A: An explicit regulatory warning notes that the concentration of Iron in the product poses a risk of severe and potentially fatal iron poisoning if accidentally ingested, particularly by a child. Official documentation specifies that overdose is managed with symptomatic and supportive treatment.


Q: How does the level of iron in Pregvit compare to standard iron supplements?

A: The pink tablet contains 35 mg of elemental iron. Regulatory documents have previously referenced other supplements containing 60 mg of iron as a point of comparison in clinical studies. The specific iron content is officially stated in the product information.


Q: What is the intended purpose of the separate iron tablet in Pregvit?

A: The tablets are separated as a mandatory requirement to optimize the absorption of key nutrients. Official documents require a separation of at least four hours to prevent mineral components, primarily Iron and Calcium, from interfering with each other's uptake during digestion.


Q: Are the ingredients in Pregvit synthetic or naturally sourced?

A: The preparation is described in official documentation as a combination product that delivers a complex mixture of substances. This includes both synthetic forms of vitamins and various mineral salts.


Q: Do I need a prescription to get Pregvit, or is it available over the counter?

A: Official product information often advises that patients should only use this medication if a healthcare provider has prescribed it. In some jurisdictions, the product is classified as a prescription-only or a Schedule II medication.


Q: Does Pregvit cause changes in my energy level?

A: The regulatory documents list fatigue as one of the possible side effects that has been documented with this medication. Fatigue is documented in the product information as a possible side effect.


Q: Is Pregvit considered a 'complete' vitamin, or do I need other nutrients?

A: Official documentation describes this product as a supplement intended to provide nutritional support. It is specified that the supplement does not replace healthy, balanced meals. The product is designed to be a supplement.


Q: Are there different versions of Pregvit available for different stages of pregnancy?

A: The product is available in different formulations, such as Pregvit and Pregvit folic 5, which contain different quantities of key ingredients, such as folic acid. The different versions address varying needs for specific nutrient levels.


Q: Is Pregvit safe to use for someone with a history of kidney stones?

A: Regulatory information for a similar product suggests that caution is required for patients with hypercalcemia (high calcium levels) or a history of renal calculi (kidney stones) due to the calcium content. This is listed as a special consideration for the use of the product.


Q: Does Pregvit contain Vitamin D, and why is that important?

A: Yes, the blue tablet contains Vitamin D3 (cholecalciferol). Authoritative sources note that Vitamin D plays a crucial role in the body, particularly in maintaining calcium homeostasis and supporting other physiological functions for both the mother and developing fetus.


Q: I have allergies; does Pregvit contain common allergens like gluten or lactose?

A: Official documentation specifically notes that this product does not contain lactose, gluten, or tartrazine as non-medicinal ingredients. Use is contraindicated, however, for anyone with a known hypersensitivity or allergy to the active ingredients.


Q: What is the role of Vitamin B6 in the Pregvit formulation?

A: Vitamin B6 (Pyridoxine) is an essential micronutrient. According to official documents on its mechanism, it serves as a cofactor in numerous metabolic transformations, including the synthesis of neurotransmitters and the regulation of homocysteine levels.


Q: Does Pregvit contain iodine, which is important for thyroid function?

A: Yes, the composition includes Iodine (Potassium Iodide). Authoritative sources confirm the critical role of iodine in supporting thyroid function, a process that is vital during pregnancy.

How should Pregvit be stored and disposed of?

Storage Requirements

Pregvit must be stored at controlled room temperature, generally defined as 15 C to 30 C (59 F to 86 F). The medication must be strictly protected from moisture and direct sunlight, and exposure to excessive heat must be avoided to maintain tablet stability. The product should be kept in its original packaging and stored securely.

Child Safety and Disposal

It is officially mandated that Pregvit be kept out of the sight and reach of children at all times. Due to its iron content, the label includes a specific regulatory warning about the risk of fatal poisoning in children under six from accidental overdose. Unused or expired Pregvit must be disposed of safely by being returned to a pharmacy take-back program. Disposal in household waste, toilets, or sinks (wastewater) is prohibited.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Pregvit found in:

A-Z Index: